牛叉诊股

[{"date":"2026.07.14","stock":"2.32","trade":"1.54","ind":"2.77"},{"date":"2026.07.13","stock":"3.44","trade":"2.88","ind":"-3.48"},{"date":"2026.07.10","stock":"0.30","trade":"1.37","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.65","trade":"-0.25","ind":"3.07"},{"date":"2026.07.08","stock":"0.30","trade":"0.73","ind":"-1.87"},{"date":"2026.07.07","stock":"-3.14","trade":"-3.32","ind":"-1.24"},{"date":"2026.07.06","stock":"2.48","trade":"0.48","ind":"-1.16"},{"date":"2026.07.03","stock":"2.59","trade":"1.67","ind":"0.64"},{"date":"2026.07.02","stock":"1.18","trade":"1.31","ind":"-3.85"},{"date":"2026.07.01","stock":"3.29","trade":"4.04","ind":"-0.53"},{"date":"2026.06.30","stock":"-2.69","trade":"-2.41","ind":"2.48"},{"date":"2026.06.29","stock":"3.97","trade":"3.70","ind":"0.19"},{"date":"2026.06.26","stock":"-3.07","trade":"-3.12","ind":"-3.44"},{"date":"2026.06.25","stock":"-2.24","trade":"-1.85","ind":"1.82"},{"date":"2026.06.24","stock":"-1.01","trade":"-2.01","ind":"1.24"},{"date":"2026.06.23","stock":"2.43","trade":"2.18","ind":"-3.17"},{"date":"2026.06.22","stock":"-1.17","trade":"-0.45","ind":"2.13"},{"date":"2026.06.18","stock":"-0.96","trade":"-0.26","ind":"0.94"},{"date":"2026.06.17","stock":"-0.85","trade":"-1.01","ind":"1.31"},{"date":"2026.06.16","stock":"-0.92","trade":"-0.94","ind":"0.93"},{"date":"2026.06.15","stock":"0.39","trade":"0.19","ind":"3.79"}]

奇正藏药,深证成指,中药指数

压力支撑

该股压力位为20.73元，支撑位为20.16元。

[{"text":"\u538b\u529b\u4f4d","value":"20.73","date":1783958400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"20.16","date":1783958400,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前正处于反弹阶段，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.6资金面打败了51%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：07月15日 08:06

机构今日流向(万元)	1273.61	机构5日流向(万元)	4375.00
机构10日流向(万元)	5972.29	机构20日流向(万元)	-1512.94

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加412.51万股，其中基金净增仓2家，主力净增仓25家，有一定的中长期投资价值。

截止2025-12-31，共33家主力机构（基金29家，一般法人4家），持仓量总计47115.75万股，占流通A股82.52%
其中，基金持仓与2025-06-30相比：
增仓：2家，增持 1.79万股
减仓：0家，减持 0万股
新出现在主力名单中：27家，持有389.12万股
从主力名单中消失：2家，原持有47.48万股

消息面诊股

诊断结果：5.6消息面打败了15%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	公司股东股份解押	2026-07-01
一般消息	股东大会	临时股东大会	2026-06-13
一般消息	重大事项	关联交易	2026-06-06
一般消息	募资投向		2026-06-01
利好	分红转增	10派4.1元(含税)	2026-04-24
一般消息	募资投向	公司出售资产	2026-04-15
一般消息	重大事项	关联交易	2026-04-08
一般消息	重大事项	公司股东股份解押	2026-03-26
一般消息	高管变动	取消监事会	2025-11-27
一般消息	高管变动	委员会调整	2025-10-27
一般消息	高管变动	因个人原因	2025-09-30
利好	分红转增	10派2.2元(含税)	2025-08-23

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：8.3行业面打败了98%的股票中药行业最新资金流向

近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，明显跑赢大盘。

[{"date":"2026.07.14","price":"2.77","value":"1.54"},{"date":"2026.07.13","price":"-3.48","value":"2.88"},{"date":"2026.07.10","price":"-2.29","value":"1.37"},{"date":"2026.07.09","price":"3.07","value":"-0.25"},{"date":"2026.07.08","price":"-1.87","value":"0.73"},{"date":"2026.07.07","price":"-1.24","value":"-3.32"},{"date":"2026.07.06","price":"-1.16","value":"0.48"},{"date":"2026.07.03","price":"0.64","value":"1.67"},{"date":"2026.07.02","price":"-3.85","value":"1.31"},{"date":"2026.07.01","price":"-0.53","value":"4.04"},{"date":"2026.06.30","price":"2.48","value":"-2.41"},{"date":"2026.06.29","price":"0.19","value":"3.70"},{"date":"2026.06.26","price":"-3.44","value":"-3.12"},{"date":"2026.06.25","price":"1.82","value":"-1.85"},{"date":"2026.06.24","price":"1.24","value":"-2.01"},{"date":"2026.06.23","price":"-3.17","value":"2.18"},{"date":"2026.06.22","price":"2.13","value":"-0.45"},{"date":"2026.06.18","price":"0.94","value":"-0.26"},{"date":"2026.06.17","price":"1.31","value":"-1.01"},{"date":"2026.06.16","price":"0.93","value":"-0.94"},{"date":"2026.06.15","price":"3.79","value":"0.19"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	众生药业	39.06%	16.10%	7.0分
2	陇神戎发	37.22%	42.84%	5.8分
3	太极集团	30.69%	29.63%	6.8分
4	华森制药	22.02%	9.67%	6.1分
5	上海凯宝	21.17%	22.83%	5.9分
6	天目药业	20.98%	5.16%	6.0分
7	特一药业	20.80%	10.70%	6.3分
8	九芝堂	17.35%	16.05%	7.1分
9	佐力药业	11.47%	7.91%	7.0分
10	以岭药业	11.15%	12.09%	7.3分
11	盘龙药业	8.62%	9.57%	5.6分
12	羚锐制药	8.20%	5.83%	7.0分
13	达仁堂	8.13%	5.92%	6.9分
14	红日药业	8.12%	7.07%	6.4分
15	维康药业	7.37%	2.52%	5.9分
16	中恒集团	6.83%	15.87%	6.0分
17	沃华医药	6.80%	4.55%	6.8分
18	片仔癀	6.79%	14.22%	6.3分
19	康缘药业	6.75%	8.09%	6.2分
20	桂林三金	6.49%	2.83%	6.5分
21	广誉远	6.26%	9.18%	6.4分
22	康恩贝	6.25%	4.17%	7.2分
23	益佰制药	5.47%	10.16%	6.0分
24	奇正藏药	5.21%	5.79%	6.0分
25	亚宝药业	4.98%	6.69%	6.7分
26	昆药集团	4.45%	8.53%	6.0分
27	精华制药	4.44%	6.07%	6.1分
28	健民集团	4.34%	-1.60%	6.0分
29	葵花药业	4.29%	5.64%	6.2分
30	华润江中	3.99%	5.18%	6.7分
31	康惠股份	3.96%	4.35%	5.4分
32	千金药业	3.91%	3.58%	6.5分
33	ST百灵	3.83%	3.83%	5.7分
34	白云山	3.52%	4.80%	6.7分
35	信邦制药	3.47%	10.37%	6.4分
36	新光药业	3.24%	7.98%	5.5分
37	吉林敖东	2.40%	0.73%	5.2分
38	仁和药业	2.25%	4.01%	5.9分
39	步长制药	2.19%	4.82%	6.5分
40	马应龙	2.08%	5.53%	6.5分
41	佛慈制药	1.85%	7.10%	6.1分
42	同仁堂	1.73%	7.19%	6.1分
43	华神科技	1.61%	4.42%	5.8分
44	方盛制药	1.54%	6.58%	6.2分
45	华润三九	1.34%	5.42%	6.7分
46	ST金花	1.03%	3.80%	5.5分
47	天士力	0.41%	3.99%	6.9分
48	振东制药	0.20%	4.97%	5.8分
49	济川药业	0.12%	9.35%	6.8分
50	东阿阿胶	0.04%	4.58%	6.1分
51	云南白药	-0.20%	2.88%	6.9分
52	-	-0.43%	7.85%	分
53	太龙药业	-0.76%	1.30%	5.2分
54	新天药业	-1.00%	4.90%	5.7分
55	汉森制药	-1.11%	5.78%	5.9分
56	-	-3.08%	9.67%	分
57	益盛药业	-3.96%	7.21%	5.7分
58	ST嘉应	-4.51%	4.63%	5.5分
59	恩威医药	-4.80%	-1.50%	5.3分
60	康美药业	-5.04%	5.60%	5.6分
61	ST万邦	-6.69%	-4.85%	6.6分
62	寿仙谷	-7.59%	4.77%	5.6分
63	ST葫芦娃	-8.50%	2.65%	5.3分
64	古汉医药	-11.69%	3.10%	5.7分
65	粤万年青	-15.69%	-4.79%	4.3分
66	珍宝岛	-18.58%	3.66%	6.0分
67	三力制药	-22.00%	-10.55%	4.8分
68	*ST香雪	-24.00%	-22.11%	4.1分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.4基本面打败了29%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：中（92.5分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 37/107 ， 1/107。

[{"date":"2026-03-31","value":"1.91","vol":"2.21"},{"date":"2025-12-31","value":"14.39","vol":"-2.33"},{"date":"2025-09-30","value":"9.55","vol":"4.80"},{"date":"2025-06-30","value":"8.85","vol":"4.03"},{"date":"2025-03-31","value":"1.87","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	1.91	14.39	9.55	8.85	1.87
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"83.93","vol":"55.05"},{"date":"2025-12-31","value":"83.05","vol":"52.85"},{"date":"2025-09-30","value":"82.25","vol":"53.29"},{"date":"2025-06-30","value":"82.19","vol":"53.82"},{"date":"2025-03-31","value":"81.53","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	83.93	83.05	82.25	82.19	81.53
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 25/107 ， 16/107。

[{"date":"2026-03-31","value":"0.56","vol":"-5.58"},{"date":"2025-12-31","value":"3.34","vol":"-6.76"},{"date":"2025-09-30","value":"3.48","vol":"-7.84"},{"date":"2025-06-30","value":"16.36","vol":"-7.78"},{"date":"2025-03-31","value":"10.39","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	0.56	3.34	3.48	16.36	10.39
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"25.77","vol":"1.06"},{"date":"2025-12-31","value":"11.36","vol":"-80.25"},{"date":"2025-09-30","value":"7.66","vol":"-2.78"},{"date":"2025-06-30","value":"10.04","vol":"2.25"},{"date":"2025-03-31","value":"-22.35","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	25.77	11.36	7.66	10.04	-22.35
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 59/107 ， 62/107。

[{"date":"2026-03-31","value":"0.06","vol":"0.12"},{"date":"2025-12-31","value":"0.35","vol":"0.47"},{"date":"2025-09-30","value":"0.23","vol":"0.35"},{"date":"2025-06-30","value":"0.17","vol":"0.24"},{"date":"2025-03-31","value":"0.06","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.06	0.35	0.23	0.17	0.06
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.21","vol":"0.59"},{"date":"2025-12-31","value":"1.71","vol":"2.34"},{"date":"2025-09-30","value":"1.16","vol":"1.72"},{"date":"2025-06-30","value":"1.07","vol":"1.17"},{"date":"2025-03-31","value":"0.37","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.21	1.71	1.16	1.07	0.37
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-40.34","vol":"5.83"},{"date":"2025-12-31","value":"25.44","vol":"30.77"},{"date":"2025-09-30","value":"3.25","vol":"10.53"},{"date":"2025-06-30","value":"30.49","vol":"22.82"},{"date":"2025-03-31","value":"63.48","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-40.34	25.44	3.25	30.49	63.48
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.07","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.89","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	1.07	-	0.89	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 37/107 ， 49/107。

[{"date":"2026-03-31","value":"3.12","vol":"2.97"},{"date":"2025-12-31","value":"2.57","vol":"2.94"},{"date":"2025-09-30","value":"2.63","vol":"3.09"},{"date":"2025-06-30","value":"2.53","vol":"2.94"},{"date":"2025-03-31","value":"2.57","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	3.12	2.57	2.63	2.53	2.57
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.71","vol":"2.23"},{"date":"2025-12-31","value":"2.30","vol":"2.15"},{"date":"2025-09-30","value":"2.39","vol":"2.24"},{"date":"2025-06-30","value":"2.36","vol":"2.15"},{"date":"2025-03-31","value":"2.41","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.71	2.30	2.39	2.36	2.41
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/107 ， 42/107。

[{"date":"2026-03-31","value":"23.56","vol":"31.94"},{"date":"2025-12-31","value":"27.77","vol":"32.43"},{"date":"2025-09-30","value":"26.92","vol":"31.59"},{"date":"2025-06-30","value":"40.16","vol":"32.45"},{"date":"2025-03-31","value":"39.40","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	23.56	27.77	26.92	40.16	39.40
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.31","vol":"0.66"},{"date":"2025-12-31","value":"0.39","vol":"0.67"},{"date":"2025-09-30","value":"0.37","vol":"0.76"},{"date":"2025-06-30","value":"0.68","vol":"0.75"},{"date":"2025-03-31","value":"0.66","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.31	0.39	0.37	0.68	0.66
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2026年的收益，请投资者后续关注。

[{"date":"2022","yellowRectValue":"4.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.81","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.82","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.48","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[奇正藏药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]